Health Economics

The criteria used to determine access to drugs, devices, and medical procedures have changed. It is no longer enough to address only the traditional clinical parameters of effectivness and safety. Your product must also show real-world efficacy and economic value. To communicate your research and message, you need writers who are versed in both the clinical and economic aspects of healthcare.

MedLitera can help. We have prepared health economics and outcomes research (HEOR) content for more than 15 years, including the following document types:

  • Academy of Managed Care Pharmacy (AMCP) dossiers, and other technical reimbursement dossiers

  • Cost-effectiveness and budget impact analyses

  • Retrospective database and patient registry studies

  • HEOR advisory board and conference coverage

  • Evaluations of health-related quality of life and patient-reported outcomes

  • Scientific content targeted to payer/purchaser audiences

  • Product- or disease-specific systematic reviews that synthesize clinical and health economics research

  • White papers, blogs, and targeted communications that describe the health and financial impact of new treatments and technologies

Download MedLitera’s article on Health Economics writing from the AMWA Journal:

Health Economics     QALY     ICER     Cost-effectiveness     AMCP Dossier     Productivity

Incremental      Payers     Managed care     Dominant strategy HEOR     Markov 

Budget Impact     Pharmacoeconomics     Real-world evidence     Retrospective database 

Transparency     MAIC     Value story     PPOs     Propensity scoring     EuroQoL

 Best Practices, Targeted and Tailored